Skip to main content
. 2009 Oct;94(10):1427–1434. doi: 10.3324/haematol.2009.008318

Figure 1.

Figure 1.

Kaplan-Meier analysis of (A) overall survival, (B) cumulative incidence of transplant-related mortality and (C) disease relapse after transplantation according to the donor NKG2D polymorphism in patients with standard-risk disease. Patients with donors with the HNK1 haplotype had better overall survival and lower transplant-related mortality. Donor haplotype had no significant impact on disease relapse.